Clinical Trial Update: Efficacy and Safety of Vespireit, Prolonged-release Tablets, in Patients With Autonomic Dysfunction Syndrome Accompanied by Functional Vertigo [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating the efficacy and safety of Vespireit prolonged-release tablets in patients with autonomic dysfunction syndrome accompanie…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autonomic Dysfunction
• Vertigo

Drugs mentioned

• Vespireit

Snippet

Sponsor: Valenta Pharm JSC | Conditions: Vertigo, Autonomic Dysfunction | Phase 4 | Status: RECRUITING